Description for Dilaudid 2mg in USA
DILAUDID 2mg (hydromorphone hydrochloride) is a hydrogenated ketone of morphine and is classified as an opioid agonist in USA. DILAUDID Tablets are available in 2 mg, 4 mg, and 8 mg strengths for oral administration, indicating the amount of hydromorphone hydrochloride in each tablet. In addition, DILAUDID Oral Solution is provided as a 5mg/5 mL (1 mg/mL) viscous liquid. The chemical name for hydromorphone hydrochloride is 4,5α-epoxy-3-hydroxy-17-methylmorphinan-6-one hydrochloride, with a molecular weight of 321.80 and a molecular formula of C17H19NO3·HCl. It is a white or almost white crystalline powder that is freely soluble in water, very slightly soluble in ethanol (96%), and practically insoluble in methylene chloride.
The inactive ingredients in the tablets include lactose anhydrous and magnesium stearate, with potential traces of sodium metabisulfite. The 2 mg tablets also contain D&C red #30 Lake dye and D&C yellow #10 Lake dye, while the 4 mg tablets additionally include D&C yellow #10 Lake dye. Each 5 mL (1 teaspoon) of DILAUDID 2mg Oral Solution contains 5 mg of hydromorphone hydrochloride, along with purified water, methylparaben, propylparaben, sucrose, and glycerin as inactive ingredients. The oral solution may also contain traces of sodium metabisulfite.
Dosage for Dilaudid 2mg in USA
The dosage for Dilaudid 2mg varies depending on the form of the medication. Dilaudid 2mg is available in tablet form with a strength of 8mg in USA. It is also available in liquid form, with each 5ml containing 5mg of the active ingredient. Additionally, Dilaudid is available in injection form as a sterile solution, with options containing 1mg, 2mg, or 4mg of hydromorphone hydrochloride, along with 0.2% sodium citrate and 0.2% citric acid solution.
For the tablet form, the usual dosage is between 2-4mg every 4-6 hours as needed. The liquid form typically begins with a dosage of 2.5mg (2.5ml) every 3-6 hours, but this may be adjusted based on the patient’s response and the doctor’s prescription.
Dilaudid 2mg should only be used in pregnant women if the potential benefit justifies the possible risk to the fetus or breastfeeding infant in USA. This drug should not be used for labor or delivery. Pregnant women taking this medication may cause the fetus or infant to become dependent on opioids, and it may have other effects on the infant. There have been no Dilaudid studies conducted on pediatric patients. For a more comprehensive view of available drug information on potential side effects when taking this medication, you can refer to our Dilaudid 2mg and Dilaudid Injection Side Effects Drug Center.
Neonatal Opioid Withdrawal Syndrome
Prolonged use of Dilaudid 2mg Oral Solution in USA or DILAUDID Tablets during pregnancy can lead to neonatal opioid withdrawal syndrome, which could be life-threatening if not identified and treated. It is crucial to manage this condition according to protocols established by neonatology experts. If opioid use is necessary for an extended period during pregnancy, it’s important to inform the patient about the risk of neonatal opioid withdrawal syndrome and ensure that appropriate treatment will be accessible.
